Relationship between FDG PET finding and oncologic gene mutation in hepatic/cholangic/pancreatic tumors
Not Applicable
- Conditions
- malignant tumor of liver, bile duct system and pancreas.
- Registration Number
- JPRN-UMIN000015737
- Lead Sponsor
- Atomic bomb disease institute, Nagasaki University
- Brief Summary
ow, analysis not including genome information are on going. Correlation between FDG uptake and histological infromation regarding tumor invasion (except lymphatic invasion) were observed in pancreatic cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Not provided
Exclusion Criteria
1: Patient with FDG PET image quality which is too poor to interpret. 2: The cases which the cancer tissue is not available.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical diagnosis, finding of FDG PET imaging and measured uptake of FDG. Pathological parameters measured on cancer sample such as invasiveness. Expression glucose transporter, hexokinese and G-6-Pase on cancer tissue. Expression and mutation of cancer related genes such as p53 on cancer tissue.
- Secondary Outcome Measures
Name Time Method